Literature DB >> 21945214

An unconventional pathway of mRNA cap formation by vesiculoviruses.

Tomoaki Ogino1, Amiya K Banerjee.   

Abstract

mRNAs of vesicular stomatitis virus (VSV), a prototype of nonsegmented negative strand (NNS) RNA viruses (e.g., rabies, measles, mumps, Ebola, and Borna disease viruses), possess the 5'-terminal cap structure identical to that of eukaryotic mRNAs, but the mechanism of mRNA cap formation is distinctly different from the latter. The elucidation of the unconventional capping of VSV mRNA remained elusive for three decades since the discovery of the cap structure in some viral and eukaryotic mRNAs in 1975. Only recently our biochemical studies revealed an unexpected strategy employed by vesiculoviruses (VSV and Chandipura virus, an emerging arbovirus) to generate the cap structure. This article summarizes the historical and current research that led to the discovery of the novel vesiculoviral mRNA capping reaction.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945214      PMCID: PMC3221763          DOI: 10.1016/j.virusres.2011.09.012

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  94 in total

Review 1.  Structure, mechanism, and evolution of the mRNA capping apparatus.

Authors:  S Shuman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  In silico identification, structure prediction and phylogenetic analysis of the 2'-O-ribose (cap 1) methyltransferase domain in the large structural protein of ssRNA negative-strand viruses.

Authors:  Janusz M Bujnicki; Leszek Rychlewski
Journal:  Protein Eng       Date:  2002-02

3.  Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains.

Authors:  O Poch; B M Blumberg; L Bougueleret; N Tordo
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

4.  Determination of the complete genomic sequence and analysis of the gene products of the virus of Spring Viremia of Carp, a fish rhabdovirus.

Authors:  Bernd Hoffmann; Heike Schütze; Thomas C Mettenleiter
Journal:  Virus Res       Date:  2002-03-20       Impact factor: 3.303

5.  Genomic organization of Borna disease virus.

Authors:  T Briese; A Schneemann; A J Lewis; Y S Park; S Kim; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Molecular diversity of the Lyssavirus genus.

Authors:  H Bourhy; B Kissi; N Tordo
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

7.  Identification of signal sequences that control transcription of borna disease virus, a nonsegmented, negative-strand RNA virus.

Authors:  A Schneemann; P A Schneider; S Kim; W I Lipkin
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase.

Authors:  D E Sleat; A K Banerjee
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Polymerase activity of in vitro mutated rabies virus L protein.

Authors:  M J Schnell; K K Conzelmann
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

Review 10.  Viral and cellular mRNA capping: past and prospects.

Authors:  Y Furuichi; A J Shatkin
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937

View more
  22 in total

Review 1.  In vitro capping and transcription of rhabdoviruses.

Authors:  Tomoaki Ogino
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 2.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

3.  The RNA triphosphatase domain of L protein of Rinderpest virus exhibits pyrophosphatase and tripolyphosphatase activities.

Authors:  Piyush Kumar Singh; Shaila Melkote Subbarao
Journal:  Virus Genes       Date:  2016-05-12       Impact factor: 2.332

4.  Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3.

Authors:  M A G Rabbani; Michael Ribaudo; Ju-Tao Guo; Sailen Barik
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

5.  HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.

Authors:  Louis-Marie Bloyet; Jérémy Welsch; François Enchery; Cyrille Mathieu; Sylvain de Breyne; Branka Horvat; Boyan Grigorov; Denis Gerlier
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  5'-Phospho-RNA Acceptor Specificity of GDP Polyribonucleotidyltransferase of Vesicular Stomatitis Virus in mRNA Capping.

Authors:  Minako Ogino; Tomoaki Ogino
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity.

Authors:  Yusuke Matsumoto; Keisuke Ohta; Daniel Kolakofsky; Machiko Nishio
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

8.  Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior.

Authors:  Kristina Brauburger; Yannik Boehmann; Verena Krähling; Elke Mühlberger
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

9.  Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.

Authors:  Vineet D Menachery; Boyd L Yount; Laurence Josset; Lisa E Gralinski; Trevor Scobey; Sudhakar Agnihothram; Michael G Katze; Ralph S Baric
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

10.  The methyltransferase domain of the Respiratory Syncytial Virus L protein catalyzes cap N7 and 2'-O-methylation.

Authors:  Priscila Sutto-Ortiz; Sergey Tcherniuk; Nina Ysebaert; Pravien Abeywickrema; Mathieu Noël; Alice Decombe; Françoise Debart; Jean-Jacques Vasseur; Bruno Canard; Dirk Roymans; Peter Rigaux; Jean-François Eléouët; Etienne Decroly
Journal:  PLoS Pathog       Date:  2021-05-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.